ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
AstraZeneca
Head of the Pricing Group at a multinational pharmaceutical company responsible for Japan pricing strategy for new drug listings and price revisions. The role sits within Pricing & Market Access and interfaces with national authorities and global teams to align local and global pricing approaches. Based in Osaka or Tokyo, reporting to senior Market Access leadership.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
AstraZeneca didn’t post a salary, so this is our estimate from similar listings.
Pricing & Health Economics Expert
JobAps
Director, Japan CMC & Devices Regulatory Affairs, New Drug Application Group
Takeda Pharmaceutical Company Limited
Pricing Analytics Manager
Takeda Pharmaceutical Company Limited
[A&V] Sr. Manager, Pricing & External Affairs
Pfizer
Corporate Counsel, Global Commercial Legal - U.S. Market Access and Pricing
AbbVie
Senior Manager, Market Access
Regeneron Pharmaceuticals